NZ512546A - Use of actylcholine esterase inhibitors to treat delirium - Google Patents

Use of actylcholine esterase inhibitors to treat delirium

Info

Publication number
NZ512546A
NZ512546A NZ512546A NZ51254699A NZ512546A NZ 512546 A NZ512546 A NZ 512546A NZ 512546 A NZ512546 A NZ 512546A NZ 51254699 A NZ51254699 A NZ 51254699A NZ 512546 A NZ512546 A NZ 512546A
Authority
NZ
New Zealand
Prior art keywords
actylcholine
esterase inhibitors
treat
treat delirium
delirium
Prior art date
Application number
NZ512546A
Inventor
Peter Fischer
Original Assignee
Sanochemia Pharmazeutika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanochemia Pharmazeutika Ag filed Critical Sanochemia Pharmazeutika Ag
Publication of NZ512546A publication Critical patent/NZ512546A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Acetylcholine esterase inhibitors are used to treat deliria, which is not caused by anti cholinergic intoxication nor by degeneration of the cholinergic system.
NZ512546A 1998-11-27 1999-11-22 Use of actylcholine esterase inhibitors to treat delirium NZ512546A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT199598 1998-11-27
PCT/AT1999/000284 WO2000032185A1 (en) 1998-11-27 1999-11-22 Use of effectors of the central cholinergic nervous system

Publications (1)

Publication Number Publication Date
NZ512546A true NZ512546A (en) 2002-11-26

Family

ID=3525562

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ512546A NZ512546A (en) 1998-11-27 1999-11-22 Use of actylcholine esterase inhibitors to treat delirium

Country Status (9)

Country Link
EP (1) EP1133290B1 (en)
JP (1) JP4422342B2 (en)
AU (1) AU768331B2 (en)
CA (1) CA2352564C (en)
DE (1) DE59904564D1 (en)
ES (1) ES2168240T3 (en)
GR (1) GR20010300072T1 (en)
NZ (1) NZ512546A (en)
WO (1) WO2000032185A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10301851A1 (en) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Use of dialkylaminoalkylphenyl carbamate derivatives to protect humans from poisoning by cholinesterase inhibitors, including pesticides and chemical warfare agents
WO2005030332A2 (en) * 2003-09-29 2005-04-07 Sanochemia Pharmazeutika Ag Use of galanthamine and the derivatives thereof in the production of medicaments
AT414125B (en) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag NEW DERIVATIVES OF 4A, 5,9,10,11,12-HEXAHYDRO-BENZOFURO (3A, 3,2) (2) BENZAZEPINE, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE FOR THE PRODUCTION OF MEDICAMENTS
EP2089028A2 (en) * 2006-11-09 2009-08-19 Avigen, Inc. Method for treating delirium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821957A3 (en) * 1996-08-01 1998-04-22 Eli Lilly And Company Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse
EP0934040A1 (en) * 1996-10-23 1999-08-11 Eli Lilly And Company Method for treating dementia due to aids
AU5495398A (en) * 1997-01-17 1998-08-07 Takeda Chemical Industries Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
WO2000032185A1 (en) 2000-06-08
EP1133290A1 (en) 2001-09-19
ES2168240T1 (en) 2002-06-16
CA2352564C (en) 2009-05-19
CA2352564A1 (en) 2000-06-08
GR20010300072T1 (en) 2001-12-31
JP4422342B2 (en) 2010-02-24
JP2002531401A (en) 2002-09-24
EP1133290B1 (en) 2003-03-12
DE59904564D1 (en) 2003-04-17
AU768331B2 (en) 2003-12-11
AU1252900A (en) 2000-06-19
ES2168240T3 (en) 2003-11-16

Similar Documents

Publication Publication Date Title
ATE217865T1 (en) COMPOUNDS FOR INHIBITING PHOSPHODIESRERASE IV
BG104780A (en) Inhibitors of phospholipase enzymes
ATE357272T1 (en) USE OF PHTHALAZINE DERIVATIVES TO TREAT NEURODEGENERATIVE DISEASES
DE69905476D1 (en) Phosphonsaürederivate als ptp-1b-inhibitoren
EP0785927A4 (en) Novel benzoxazoles
AP1498A (en) Inhibitors of impdh enzyme.
DK0966465T3 (en) Inhibitors of IMPDH enzymes
IL151313A0 (en) Lipase containing pharmaceutical compositions
AP9901478A0 (en) Compounds for the treatment of ischemia.
AU2001248701A1 (en) Inhibitors of histone deacetylase
DE69612003D1 (en) SUBSTITUTED BENZOLACTATE COMPOUNDS AS SUBSTANCE P-ANTAGONISTS
IL128062A0 (en) Bicyclic pyrimidine derivatives and pharmaceutical compositions containing the same
BR9712831A (en) Tricyclic farnesyl protein transferase inhibitors
WO2001010383A3 (en) Caspase inhibitors and uses thereof
AU4384397A (en) Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
WO2000043373A3 (en) Kinase inhibitors
UA66865C2 (en) Indenopyrrolocarbazoles, pharmaceutical composition, method for inhibiting kinase activity and method for treatment (variants)
IL125285A0 (en) Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and pharmaceutical compositions containing the same
ATE311388T1 (en) PYRIMIDOTRIAZINES AS PHOSPHATASE INHIBITORS
AU2336497A (en) Metal mediated serine protease inhibitors
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
WO1997038966A3 (en) Cytoprotective compounds
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
NZ512546A (en) Use of actylcholine esterase inhibitors to treat delirium

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired